id todo:paper_07533322_v65_n3_p210_FernandezCalienes
record_format dspace
spelling todo:paper_07533322_v65_n3_p210_FernandezCalienes2023-10-03T15:39:37Z Antimalarial activity of new acridinone derivatives Fernández-Calienes, A. Pellón, R. Docampo, M. Fascio, M. D'Accorso, N. Maes, L. Mendiola, J. Monzote, L. Gille, L. Rojas, L. Acridinone Antimalarial activity Plasmodium falciparum 10 (1,2 propadienyl) 9 (10h) acridinone 10 (3 methyl 2 butenyl) 9 (10h) acridinone 10 allyl 9 (10h) acridinone antimalarial agent atovaquone beta hematin chloroquine heme derivative stigmatellin unclassified drug animal cell antimalarial activity article controlled study cow cytotoxicity drug selectivity heart muscle cell human human cell IC 50 nonhuman Plasmodium falciparum priority journal spectrophotometry yeast Acridines Animals Antimalarials Cattle Cell Line Drug Resistance, Microbial Hemeproteins Humans Malaria Plasmodium falciparum Yeasts Malaria is one of the major threats concerning world public health. Resistance to the current antimalarial drugs has led to searches for new antimalarial compounds. Acridinone derivatives have recently demonstrated to be active against malaria parasite. We focused our attention on synthesized new acridinone derivatives, some of them resulting with high antiviral and trypanocidal activity. In this study new derivatives of 10-alyl-, 10-(3-methyl-2-butenyl)- and 10-(1,2-propadienyl)-9(10H)-acridinone were evaluated for their antimalarial activity against Plasmodium falciparum. To assess the selectivity, cytotoxicity was assessed in parallel against human MRC-5 cells. Inhibition of β-hematin formation was determined using a spectrophotometric assay. Mitochondrial bc 1 complexes were isolated from yeast and bovine heart cells to test acridinone inhibitory activity. This study resulted in the identification of three compounds with submicromolar efficacy against P. falciparum and without cytotoxic effects on human cellular line. One compound, IIa (1-fluoro-10-(3-methyl-2-butenyl)-9(10H)-acridinone), can be classified as hit for antimalarial drug development exhibiting IC 50 less than 0.2μg/mL with SI greater than 100. In molecular tests, no relevant inhibitory activity was obtained for our compounds. The mechanism of acridinones antimalarial action remains unclear. © 2011 Elsevier Masson SAS. Fil:Fascio, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:D'Accorso, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_07533322_v65_n3_p210_FernandezCalienes
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Acridinone
Antimalarial activity
Plasmodium falciparum
10 (1,2 propadienyl) 9 (10h) acridinone
10 (3 methyl 2 butenyl) 9 (10h) acridinone
10 allyl 9 (10h) acridinone
antimalarial agent
atovaquone
beta hematin
chloroquine
heme derivative
stigmatellin
unclassified drug
animal cell
antimalarial activity
article
controlled study
cow
cytotoxicity
drug selectivity
heart muscle cell
human
human cell
IC 50
nonhuman
Plasmodium falciparum
priority journal
spectrophotometry
yeast
Acridines
Animals
Antimalarials
Cattle
Cell Line
Drug Resistance, Microbial
Hemeproteins
Humans
Malaria
Plasmodium falciparum
Yeasts
spellingShingle Acridinone
Antimalarial activity
Plasmodium falciparum
10 (1,2 propadienyl) 9 (10h) acridinone
10 (3 methyl 2 butenyl) 9 (10h) acridinone
10 allyl 9 (10h) acridinone
antimalarial agent
atovaquone
beta hematin
chloroquine
heme derivative
stigmatellin
unclassified drug
animal cell
antimalarial activity
article
controlled study
cow
cytotoxicity
drug selectivity
heart muscle cell
human
human cell
IC 50
nonhuman
Plasmodium falciparum
priority journal
spectrophotometry
yeast
Acridines
Animals
Antimalarials
Cattle
Cell Line
Drug Resistance, Microbial
Hemeproteins
Humans
Malaria
Plasmodium falciparum
Yeasts
Fernández-Calienes, A.
Pellón, R.
Docampo, M.
Fascio, M.
D'Accorso, N.
Maes, L.
Mendiola, J.
Monzote, L.
Gille, L.
Rojas, L.
Antimalarial activity of new acridinone derivatives
topic_facet Acridinone
Antimalarial activity
Plasmodium falciparum
10 (1,2 propadienyl) 9 (10h) acridinone
10 (3 methyl 2 butenyl) 9 (10h) acridinone
10 allyl 9 (10h) acridinone
antimalarial agent
atovaquone
beta hematin
chloroquine
heme derivative
stigmatellin
unclassified drug
animal cell
antimalarial activity
article
controlled study
cow
cytotoxicity
drug selectivity
heart muscle cell
human
human cell
IC 50
nonhuman
Plasmodium falciparum
priority journal
spectrophotometry
yeast
Acridines
Animals
Antimalarials
Cattle
Cell Line
Drug Resistance, Microbial
Hemeproteins
Humans
Malaria
Plasmodium falciparum
Yeasts
description Malaria is one of the major threats concerning world public health. Resistance to the current antimalarial drugs has led to searches for new antimalarial compounds. Acridinone derivatives have recently demonstrated to be active against malaria parasite. We focused our attention on synthesized new acridinone derivatives, some of them resulting with high antiviral and trypanocidal activity. In this study new derivatives of 10-alyl-, 10-(3-methyl-2-butenyl)- and 10-(1,2-propadienyl)-9(10H)-acridinone were evaluated for their antimalarial activity against Plasmodium falciparum. To assess the selectivity, cytotoxicity was assessed in parallel against human MRC-5 cells. Inhibition of β-hematin formation was determined using a spectrophotometric assay. Mitochondrial bc 1 complexes were isolated from yeast and bovine heart cells to test acridinone inhibitory activity. This study resulted in the identification of three compounds with submicromolar efficacy against P. falciparum and without cytotoxic effects on human cellular line. One compound, IIa (1-fluoro-10-(3-methyl-2-butenyl)-9(10H)-acridinone), can be classified as hit for antimalarial drug development exhibiting IC 50 less than 0.2μg/mL with SI greater than 100. In molecular tests, no relevant inhibitory activity was obtained for our compounds. The mechanism of acridinones antimalarial action remains unclear. © 2011 Elsevier Masson SAS.
format JOUR
author Fernández-Calienes, A.
Pellón, R.
Docampo, M.
Fascio, M.
D'Accorso, N.
Maes, L.
Mendiola, J.
Monzote, L.
Gille, L.
Rojas, L.
author_facet Fernández-Calienes, A.
Pellón, R.
Docampo, M.
Fascio, M.
D'Accorso, N.
Maes, L.
Mendiola, J.
Monzote, L.
Gille, L.
Rojas, L.
author_sort Fernández-Calienes, A.
title Antimalarial activity of new acridinone derivatives
title_short Antimalarial activity of new acridinone derivatives
title_full Antimalarial activity of new acridinone derivatives
title_fullStr Antimalarial activity of new acridinone derivatives
title_full_unstemmed Antimalarial activity of new acridinone derivatives
title_sort antimalarial activity of new acridinone derivatives
url http://hdl.handle.net/20.500.12110/paper_07533322_v65_n3_p210_FernandezCalienes
work_keys_str_mv AT fernandezcalienesa antimalarialactivityofnewacridinonederivatives
AT pellonr antimalarialactivityofnewacridinonederivatives
AT docampom antimalarialactivityofnewacridinonederivatives
AT fasciom antimalarialactivityofnewacridinonederivatives
AT daccorson antimalarialactivityofnewacridinonederivatives
AT maesl antimalarialactivityofnewacridinonederivatives
AT mendiolaj antimalarialactivityofnewacridinonederivatives
AT monzotel antimalarialactivityofnewacridinonederivatives
AT gillel antimalarialactivityofnewacridinonederivatives
AT rojasl antimalarialactivityofnewacridinonederivatives
_version_ 1807323657408610304